Société de Therapeutique Marocaine S.A. (CBSE:SOT)

Morocco flag Morocco · Delayed Price · Currency is MAD
1,787.00
+37.00 (2.11%)
At close: Dec 4, 2025
92.15%
Market Cap 12.81B
Revenue (ttm) 3.04B
Net Income (ttm) 345.28M
Shares Out 7.20M
EPS (ttm) 47.96
PE Ratio 37.76
Forward PE 34.15
Dividend 28.00 (1.57%)
Ex-Dividend Date Jun 20, 2025
Volume 162
Average Volume 61
Open 1,755.00
Previous Close 1,750.00
Day's Range 1,750.00 - 1,787.00
52-Week Range 906.00 - 1,950.00
Beta -0.03
RSI 48.60
Earnings Date Jul 31, 2025

About CBSE:SOT

Société de Therapeutique Marocaine S.A., a pharmaceutical company, engages in the manufacturing of licensed medicines in Morocco. It offers products in various therapeutic areas, such as allergology, oncology, cardiology, dental, dermatology, endocrinology, gastroenterology, gynecology, ophthalmology, ENT, pediatric, pulmonology, reanimation, rheumatology, central nervous system (CNS), and urology, as well as antibiotics and generics. The company also provides its products in various forms, including tablets, capsules, pouches, syrups, suspensi... [Read more]

Industry Pharmaceutical Preparations
Founded 1976
Employees 1,316
Stock Exchange Casablanca Stock Exchange
Ticker Symbol SOT
Full Company Profile

Financial Performance

In 2024, CBSE:SOT's revenue was 2.82 billion, an increase of 13.27% compared to the previous year's 2.49 billion. Earnings were 315.29 million, an increase of 19.99%.

Financial Statements

News

There is no news available yet.